美国NDC复合药物数据库文件

药品名称：商品名称：药品NDC：报告期内： -格式:2020-5-3
NDC包装id：市场分类：活性成分：持证企业：

美国NDC复合药物数据库文件4843条(本栏目更新到2026-3-31)

药品名称(分析)

商品名

药品NDC

专利人(分析)

报告期内

活性成分

市场分类

规格(分析)

NDC包装id

031022 DEXAMETHASONE SODIUM PHOSPHATE 0.1% / FINASTERIDE 0.1% / MINOXIDIL 5% / TRETINOIN 0.025%

HUMAN COMPOUNDED DRUG

72934-4346

SKNV

2024-2

DEXAMETHASONE SODIUM PHOSPHATE; FINASTERIDE; TRETINOIN; MINOXIDIL

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 g/100 mL; .1 g/100 mL; .025 g/100 mL; 5 g/100 mL

72934-4346-8

031080 BETAMETHASONE DIPROPIONATE 0.05% / MINOXIDIL 7%

HUMAN COMPOUNDED DRUG

72934-4350

SKNV

2024-2

MINOXIDIL; BETAMETHASONE DIPROPIONATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

7 g/100 mL; .05 g/100 mL

72934-4350-8

011517 BENZOYL PEROXIDE 2.5% / CLINDAMYCIN 1% / NIACINAMIDE 4% Gel

HUMAN COMPOUNDED DRUG

72934-1326

SKNV

2024-2

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; NIACINAMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

2.5 g/100 mL; 1 g/100 mL; 4 g/100 mL

72934-1326-2

011022 CLINDAMYCIN 1% / NIACINAMIDE 4% / TRETINOIN 0.05% Cream

HUMAN COMPOUNDED DRUG

72934-2305

SKNV

2024-2

TRETINOIN; NIACINAMIDE; CLINDAMYCIN PHOSPHATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.05 g/100 mL; 4 g/100 mL; 1 g/100 mL

72934-2305-2

141017 HYDROCORTISONE 0.5% / HYDROQUINONE 6% / TRETINOIN 0.025%

HUMAN COMPOUNDED DRUG

72934-6376

SKNV

2024-1

HYDROCORTISONE; HYDROQUINONE; TRETINOIN

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.5 g/100 mL; 6 g/100 mL; .025 g/100 mL

72934-6376-2

091088 CLOBETASOL PROPIONATE 0.05% / NIACINAMIDE 4%

HUMAN COMPOUNDED DRUG

72934-5364

SKNV

2024-1

CLOBETASOL PROPIONATE; NIACINAMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.05 g/100 mL; 4 g/100 mL

72934-5364-3

171010 BRIMONIDINE TARTRATE 0.25%

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.25 g/100 mL

72934-1396-2

171082 BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%

HUMAN COMPOUNDED DRUG

72934-1399

SKNV

2024-1

NIACINAMIDE; IVERMECTIN; METRONIDAZOLE; BRIMONIDINE TARTRATE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

4 g/100 mL; 1 g/100 mL; 1 g/100 mL; .25 g/100 mL

72934-1399-2

011728 BENZOYL PEROXIDE 10% / SPIRONOLACTONE 4% CLINDAMYCIN 2% / NIACINAMIDE 4% / TRETINOIN 0.1%

HUMAN COMPOUNDED DRUG

72934-1441

SKNV

2024-1

TRETINOIN; BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE; SPIRONOLACTONE; NIACINAMIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.1 g/100 g; 10 g/100 g; 2 g/100 g; 4 g/100 g; 4 g/100 g

72934-1441-1

Morphine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1010-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1030

OurPharma LLC

2023-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

.2 mg/1 mL

73013-1030-1

Morphine Sulfate

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1021-1

Hydromorphone HCl

HUMAN COMPOUNDED DRUG

73013-1045

OurPharma LLC

2023-2

HYDROMORPHONE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

1 mg/1 mL

73013-1045-1

Ketamine HCl

HUMAN COMPOUNDED DRUG

73013-2002

OurPharma LLC

2023-2

KETAMINE HYDROCHLORIDE

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg/1 mL

73013-2002-1

TESTOSTERONE C 37.5MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

37.5 mg

70713-038-01

TESTOSTERONE C 50MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

70713-023-01

PROGESTERONE SA2 100MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

100 mg

70713-026-01

TESTOSTERONE SA2 50MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

50 mg

70713-004-01

ESTRADIOL 18MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

18 mg

70713-144-01

ESTRADIOL 10MG

HUMAN COMPOUNDED DRUG

OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)

10 mg

70713-056-01

网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:330683240604819103159
　医药代理商群１：

医药代理商群２：

医药代理商群３：